These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25469631)

  • 21. Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome.
    Pericleous C; Clarke LA; Brogan PA; Latchman DS; Isenberg DA; Ioannou Y; Giles IP; Rahman A
    Thromb Haemost; 2013 Jan; 109(1):72-8. PubMed ID: 23152159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies in obstetrics: new complexities and sites of action.
    Caruso A; De Carolis S; Di Simone N
    Hum Reprod Update; 1999; 5(3):267-76. PubMed ID: 10438111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
    Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
    Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation and recommended testing for antiphospholipid antibodies.
    Galli M
    Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
    Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
    Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome.
    Bontadi A; Ruffatti A; Marson P; Tison T; Tonello M; Hoxha A; De Silvestro G; Punzi L
    J Clin Apher; 2012; 27(4):200-4. PubMed ID: 22532158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules.
    Di Simone N; Castellani R; Caliandro D; Caruso A
    Fertil Steril; 2002 Apr; 77(4):805-11. PubMed ID: 11937138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensibility and specificity for pregnancy morbidity of anti-β2-glycoprotein I antibodies in antiphospholipid syndrome].
    Tonello M; Ruffatti A; Favaro M; Del Ross T; Zamboni D; Grypiotis P; Cavazzana A; Ciprian M; Todesco S
    Reumatismo; 2005 Dec; 57(4):262-6. PubMed ID: 16380753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory Evaluation of Antiphospholipid Syndrome.
    Heikal N; Martins TB; White SK; Willis R; Ware Branch D; Schmidt RL; Tebo AE
    Am J Clin Pathol; 2019 Oct; 152(5):638-646. PubMed ID: 31305881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
    Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
    Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does seronegative obstetric APS exist? "pro" and "cons".
    Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
    Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstetric Antiphospholipid Syndrome: An Approach from Glycans of the Immunoglobulin G.
    Alvarez AM; Gomez-Gutierrez AM; Bueno-Sánchez JC; Rúa-Molina C; Cadavid AP
    J Hum Reprod Sci; 2021; 14(1):97-100. PubMed ID: 34084001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators.
    Mulla MJ; Weel IC; Potter JA; Gysler SM; Salmon JE; Peraçoli MTS; Rothlin CV; Chamley LW; Abrahams VM
    Arthritis Rheumatol; 2018 Jun; 70(6):891-902. PubMed ID: 29342502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I].
    Andreoli L; Nalli C; Motta M; Norman GL; Binder WL; Nuzzo M; Frassi M; Lojacono A; Avcin T; Meroni PL; Tincani A
    Reumatismo; 2010; 62(3):189-94. PubMed ID: 21052565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
    Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
    Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.
    Di Simone N; Marana R; Castellani R; Di Nicuolo F; D'Alessio MC; Raschi E; Borghi MO; Chen PP; Sanguinetti M; Caruso A; Meroni PL
    Arthritis Rheum; 2010 May; 62(5):1504-12. PubMed ID: 20131286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.